Pablo Davis

Dinsmore & Shohl LLP

+ Follow Contact

Latest Posts › Prescription Drugs

Share:

First Circuit Poised to Consider Anti-Kickback Statute’s Causation Element in FCA Cases, Take a Position on Circuit Split

Conflicting interpretations of the causation standard in two AKS-predicated False Claims Act cases in the District of Massachusetts, Teva and Regeneron, mirrored the circuit split on the issue and led to interlocutory appeals...more

6/28/2024 / Anti-Kickback Statute , False Claims Act (FCA) , Health Care Providers , Healthcare Fraud , Pharmaceutical Industry , Prescription Drugs

1 Results

View per page

Page: of 1

Pablo Davis

Dinsmore & Shohl LLP

Popular Topics by This Author

Latest Posts › Prescription Drugs

First Circuit Poised to Consider Anti-Kickback Statute’s Causation Element in FCA Cases, Take a Position on Circuit Split

"My best business intelligence, in one easy email…"